Impact of Extrafine Formulation Single-inhaler Triple Therapy on Asthma Control and Health-related Quality of Life After Three Months of Treatment in Patients With Asthma: Trimaximize - A Real-world View From Germany, United Kingdom, Austria and Denmark

被引：0

作者：

Gessner, C. ^{[1
]}

Akyildiz, B. ^{[2
]}

Pohl, W. ^{[3
]}

Nachtigall, D. ^{[2
]}

Russell, R. ^{[4
]}

Bogoevska, V. ^{[2
]}

Ulrik, C. S. ^{[5
]}

Watz, H. ^{[6
]}

机构：

[1] Specialized Practice Pulm Med, Leipzig, Germany

[2] Chiesi GmbH, Hamburg, Germany

[3] Hietzing Hosp, Karl Landsteiner Inst Clin & Expt Pneumol, Vienna, Austria

[4] Univ Oxford, Oxford, England

[5] Hvidovre Univ Hosp, Dept Pulm Med, Hvidovre, Denmark

[6] LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A6649

引用

页数：2

共 30 条

[11] Change in health-related quality of life after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Koczulla, A.
Akyildiz, B.
Slawinska, R.
Martini, M.
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S35 - S35
[12] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Greulich, T.
Akyildiz, B.
Nachtigall, D.
Bogoevska, V
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S29 - S29
[13] First Real-World Evidence on High Dose Strength of Extrafine Single-Inhaler Triple Therapy in Asthma Patients after Three Months of Treatment TriMaximize Study
Gessner, C.
Bogoevska, V
Nachtigall, D.
Akyildiz, B.
Martini, M.
Wendt, A.
Criee, C.
PNEUMOLOGIE, 2024, 78 : S4 - S4
[14] Extrafine Formulation Single-inhaler Triple Therapy Improves Lung Function After Six Months of Treatment in Patients With Asthma: Trimaximize Study
Gessner, C.
Bogoevska, V.
Nachtigall, D.
Russell, R.
Ulrik, C. S.
Pohl, W.
Plaza, V.
Bourdin, A.
Akyildiz, B.
Trinkmann, F.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[15] Real-World Outcomes on Spacer used with Extrafine Single-Inhaler Triple Therapy in Asthma Patients-TriMaximize Study
Trinkmann, F.
Nachtigall, D.
Bogoevska, V
Akyildiz, B.
Borucki, T.
Grickschat, V
Gessner, C.
PNEUMOLOGIE, 2024, 78 : S4 - S4
[16] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
Trinkmann, Autoren F.
Akyildiz, B.
Grickschat, V
Borucki, T.
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S35 - S36
[17] Change in asthma control after three months of treatment with extrafine formulation singleinhaler triple therapy in patients with asthma: the TriMaximize study
Greulich, Timm
Akyildiz, Berktan
Pohl, Wolfgang
Nachtigall, Detlef
Russell, Richard
Bogoevska, Valentina
Ulrik, Charlotte Suppli
Slawinska, Renata
Gessner, Christian
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[18] The Use of Inflammation Parameters in the Care of Patients with Asthma Prescribed Extrafine Single-Inhaler Triple Therapy: A Real-World View from Germany
Gessner, C.
Akyildiz, B.
Nachtigall, D.
Nudo, E.
Boeing, S.
Timmermann, H.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
[19] Improvement in lung function after six months of treatment with extrafine formulation single-inhaler triple therapy (efSITT) in patients with asthma-TriMaximize Study
Gessner, Christian
Bogoevska, Valentina
Nachtigall, Detlef
Russell, Richard
Ulrik, Charlotte Suppli
Pohl, Wolfgang
Plaza, Vicente
Bourdin, Arnaud
Criee, Carl-Peter
Trinkmann, Frederik
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[20] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Gessner, C.
Akyildiz, B.
Grickschat, V
Borucki, T.
Trinkmann, F.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60

← 1 2 3 →